Curanex Pharmaceuticals Inc SEC filings CURX
Curanex Pharmaceuticals Inc has 65 filings in SEC EDGAR's recent list, going back to Jun 20, 2024. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 19, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 4, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Aug 17, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Other events
|
May 7, 2026 | May 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2026 | Apr 2, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Mar 6, 2026 | Mar 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Nov 6, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Sep 29, 2025 | Sep 23, 2025 |
| 8-K |
Current report
Other events
|
Sep 12, 2025 | Sep 12, 2025 |
| 8-K |
Current report
Other events
|
Aug 27, 2025 | Aug 27, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 26, 2025 | Aug 25, 2025 |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CURX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Jericho, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2025942
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.